跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
醋酸兰瑞肽缓释注射液(预充式) - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lanreotide acetate sustained-release injection (a pre-filled syringe)
Approved
化学药品
Lanreotide acetate sustained-release injection (a pre-filled syringe)
IPSEN PHARMA
🇨🇳 National Medical Products Administration
Approval Date
May 22, 2024
Approval ID
8bLXyBXIEj5
Company
IPSEN PHARMA
Type
化学药品
Approval Details
Approval Id
8bLXyBXIEj5
Approval Number
国药准字HJ20190059
Generic Name
醋酸兰瑞肽缓释注射液(预充式)
Generic Name En
Lanreotide acetate sustained-release injection (a pre-filled syringe)
Drug Type
化学药品
Dosage Form
注射剂
Strength
120mg (以C₅₄H₆₉N₁₁O₁₀S₂计)
Reg Date
2024-05-22
Expired Date
2029-05-21
Company Name
IPSEN PHARMA
Production Company Name
IPSEN PHARMA BIOTECH
Company Detail Path
/organization/ipsen-pharma
Production Company Detail Path
/organization/ipsen-pharma-biotech
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 22, 2024
Approval ID
8bLXyBXIEj5
Type
化学药品
Back to NMPA Approvals